Search Results - "Aries, James"

Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients by Aries, James A., Davies, Jeffrey K., Auer, Rebecca L., Hallam, Simon L., Montoto, Silvia, Smith, Matthew, Sevillano, Belen, Foggo, Vanessa, Wrench, Bela, Zegocki, Krzysztof, Agrawal, Samir, Le Dieu, Rifca, Truelove, Edward, Erblich, Thomas, Araf, Shamzah, Okosun, Jessica, Oakervee, Heather, Cavenagh, Jamie D., Gribben, John G., Riches, John C.

Get full text

2022 update on the clinical outcome of coronavirus disease 2019 in haemato-oncology patients by Bradwell, Susie, Hone, Luke, Thorneycroft, Kirstie, Lambourne, Jonathan, Aries, James A, Davies, Jeffrey K, Cutino-Moguel, Teresa, Riches, John C

Get full text

P1253: REDUCED EXPRESSION OF THE CHEMOKINES CXCL2, CXCL3 AND CXCL8 PROVIDES A POTENTIAL MECHANISM PROMOTING IMMUNE EVASION FACILITATING AML RELAPSE FOLLOWING ALLOGENEIC HSCT by Charrot, Sarah, Ball, Jennifer, Copley, Findlay, Aries, James, Mee, Matthew, Theocharidis, Symeon, Heward, James, Gribben, John, Davies, Jeff

Get full text

P1254: BASELINE HLA‐DR‐RESTRICTED NEOANTIGEN BURDEN OF AML BLASTS IMPACTS ON HLA‐DR GENE EXPRESSION AT RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT by Charrot, Sarah, Ball, Jennifer, Copley, Findlay, Aries, James, Mee, Matthew, Theocharidis, Symeon, Heward, James, Gribben, John, Davies, Jeff

Get full text

Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients by Caldwell, Louise, Bapat, Anjaneya, Drumright, Lydia N, Lambourne, Jonathan, Jimenez-England, Fergus G, Aries, James, Eccersley, Lydia, Hallam, Simon, Montoto, Silvia, Oakervee, Heather, Riches, John, Agrawal, Samir G

Get full text

FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML by Othman, Jad, Potter, Nicola, Mokretar, Katya, Taussig, David, Khan, Anjum, Krishnamurthy, Pramila, Latif, Anne-Louise, Cahalin, Paul, Aries, James, Amer, Mariam, Belsham, Edward, Conneally, Eibhlin, Craddock, Charles, Culligan, Dominic, Dennis, Mike, Duncan, Caroline, Freeman, Sylvie D., Furness, Caroline, Gilkes, Amanda, Gkreka, Paraskevi, Hodgson, Katherine, Ingram, Wendy, Jain, Manish, King, Andrew, Knapper, Steven, Kottaridis, Panagiotis, McMullin, Mary Frances, Mohite, Unmesh, Ngu, Loretta, O’Nions, Jenny, Patrick, Katharine, Rider, Tom, Roberts, Wing, Severinsen, Marianne Tang, Storrar, Neill, Taylor, Tom, Russell, Nigel H., Dillon, Richard

“…Patients with FLT3 -mutated AML have a high relapse rate and suboptimal outcomes. Many have co-mutations suitable for measurable residual disease (MRD)…”
Get full text

Managing HIV and Hodgkin Lymphoma in the Twenty-first century by Aries, James, Montoto, Silvia

“…Hodgkin lymphoma (HL) is more frequent in patients with Human Immunodeficiency Virus (HIV) infection than in immunocompetent patients. The relationship between…”
Get full text

Integrated Immune Signature Analyses Identifies Evolution of Distinct Immunoregulatory Cell Populations Which Control Alloreactivity after Allogeneic HSCT by Aries, James, Charrot, Sarah, Ball, Jennifer, Mee, Matthew, Theocharidis, Symeon, Van Gassen, Sofie, Iqbal, Sameena, Gribben, John G., Davies, Jeff

“…Background. Treatment failure after allogeneic haematopoietic stem-cell transplantation (AHST) using reduced-intensity conditioning (RIC) results from too much…”
Get full text

Retinoic acid–responsive CD8 effector T cells are selectively increased in IL-23–rich tissue in gastrointestinal GVHD by Ball, Jennifer A., Clear, Andrew, Aries, James, Charrot, Sarah, Besley, Caroline, Mee, Matt, Stagg, Andrew, Lindsay, James O., Cavenagh, Jamie, Calaminci, Maria, Gribben, John G., Davies, Jeff

“…Gastrointestinal (GI) graft-versus-host disease (GVHD) is a major barrier in allogeneic hematopoietic stem cell transplantation (allo-HSCT). The metabolite…”
Get full text

Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience by Jurgensen‐Rauch, Amanda, Gibbs, Suzanne, Farrell, Maresa, Aries, James, Grantham, Marianne, Eccersley, Lydia, Gribben, John, Hallam, Simon, Oakervee, Heather, Cavenagh, Jamie, Davies, Jeff, Sive, Jonathan

Get full text

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy by Booth, Stephen, Curley, Helen M., Varnai, Csilla, Arnold, Roland, Lee, Lennard Y. W., Campton, Naomi A., Cook, Gordon, Purshouse, Karin, Aries, James, Innes, Andrew, Cook, Lucy B., Tomkins, Oliver, Oram, Helen S., Tilby, Michael, Kulasekararaj, Austin, Wrench, David, Dolly, Saoirse, Newsom‐Davies, Tom, Pettengell, Ruth, Gault, Abigail, Moody, Sam, Mittal, Sajjan, Altohami, Mohammed, Tillet, Tania, Illingworth, Jack, Mukherjee, Leena, Apperly, Jane, Ashcroft, John, Rabin, Neil, Carmichael, Jonathan, Cazier, Jean‐Baptiste, Kerr, Rachel, Middleton, Gary, Collins, Graham P., Palles, Claire

“…Summary Patients with haematological malignancies have a high risk of severe infection and death from SARS‐CoV‐2. In this prospective observational study, we…”
Get full text

Venetoclax-Based Non-Intensive Combinations Successfully Salvage Molecular Relapse of Acute Myeloid Leukemia and Are an Important Bridge to Cellular Therapy in Relapsed/Refractory Disease - Real-World Data from a UK-Wide Programme by Wood, Henry, Bourlon, Christianne, Kulasekararaj, Austin, Borg, Albert, Pavlu, Jiri, Elder, Patrick, Taussig, David C, Veitch, Scott, Knapper, Steven, Othman, Jad, Dillon, Richard, Aries, James, Mitchell, Emily, Basheer, Faisal, Leak, Steven, Murthy, Vidhya, Cross, Joe W, Mehta, Priyanka, Jain, Manish, Khan, Anjum, Lam, Ho, Leong, Sarah, O'Nions, Jenny, Craddock, Charles, Potter, Victoria, Copland, Mhairi, Krishnamurthy, Pramila

Get full text

High Molecular Response Rate and Overall Survival with FLT3 Inhibitors As MRD-Guided Salvage Treatment for Molecular Failure in AML by Othman, Jad, Potter, Nicola, Mokretar, Katya, Taussig, David, Khan, Anjum, Krishnamurthy, Pramila, Latif, Anne-Louise, Cahalin, Paul, Aries, James, Amer, Mariam, Belsham, Edward, Conneally, Eibhlin, Craddock, Charles, Culligan, Dominic, Dennis, Mike, Duncan, Caroline, Furness, Caroline, Gkreka, Paraskevi, Hodgson, Katherine, Ingram, Wendy, King, Andrew, Kottaridis, Panagiotis, McMullin, Mary Frances, Mohite, Unmesh, Ngu, Loretta, Patrick, Katharine, Rider, Tom, Roberts, Wing, Severinsen, Marianne Tang, Storrar, Neill, Taylor, Tom, Russell, Nigel H., Dillon, Richard

Get full text

Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML by Jimenez-Chillon, Carlos, Othman, Jad, Taussig, David, Jimenez-Vicente, Carlos, Martinez-Roca, Alexandra, Tiong, Ing Soo, Jain, Manish, Aries, James, Cakmak, Seda, Knapper, Steven, Kristensen, Daniel Tuyet, Murthy, Vidhya, Galani, Joy Zacharoula, Kallmeyer, Charlotte, Ngu, Loretta, Veale, David, Bolam, Simon, Orfali, Nina, Parker, Anne, Manson, Cara, Parker, Jane, Erblich, Thomas, Richardson, Deborah, Mokretar, Katya, Potter, Nicola, Overgaard, Ulrik Malthe, Roug, Anne Stidsholt, Wei, Andrew H, Esteve, Jordi, Jädersten, Martin, Russell, Nigel, Dillon, Richard

“…Molecular failure in NPM1-mutated acute myeloid leukemia (AML) inevitably progresses to frank relapse if untreated. Recently published small case series show…”
Get full text

Nonconvulsive status epilepticus and leucoencephalopathy after high-dose methotrexate by Patterson, Daniel M, Aries, James, Hyare, Harpreet, Holder, David, Rees, Jeremy, Lee, Siow Ming

Get full text